| pubmed-article:10831902 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10831902 | lifeskim:mentions | umls-concept:C2325187 | lld:lifeskim |
| pubmed-article:10831902 | lifeskim:mentions | umls-concept:C0205095 | lld:lifeskim |
| pubmed-article:10831902 | lifeskim:mentions | umls-concept:C1299003 | lld:lifeskim |
| pubmed-article:10831902 | lifeskim:mentions | umls-concept:C0003241 | lld:lifeskim |
| pubmed-article:10831902 | lifeskim:mentions | umls-concept:C2936390 | lld:lifeskim |
| pubmed-article:10831902 | lifeskim:mentions | umls-concept:C0023981 | lld:lifeskim |
| pubmed-article:10831902 | lifeskim:mentions | umls-concept:C1705187 | lld:lifeskim |
| pubmed-article:10831902 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:10831902 | pubmed:dateCreated | 2000-7-31 | lld:pubmed |
| pubmed-article:10831902 | pubmed:abstractText | To evaluate the intraocular safety of an immunoconjugate (MDX-RA) developed to prevent posterior capsule opacification (PCO) in human eyes. | lld:pubmed |
| pubmed-article:10831902 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10831902 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10831902 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10831902 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10831902 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10831902 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10831902 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10831902 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10831902 | pubmed:month | May | lld:pubmed |
| pubmed-article:10831902 | pubmed:issn | 0886-3350 | lld:pubmed |
| pubmed-article:10831902 | pubmed:author | pubmed-author:SpaltonD JDJ | lld:pubmed |
| pubmed-article:10831902 | pubmed:author | pubmed-author:BoyceJ FJF | lld:pubmed |
| pubmed-article:10831902 | pubmed:author | pubmed-author:BarmanSS | lld:pubmed |
| pubmed-article:10831902 | pubmed:author | pubmed-author:HollickE JEJ | lld:pubmed |
| pubmed-article:10831902 | pubmed:author | pubmed-author:MeacockW RWR | lld:pubmed |
| pubmed-article:10831902 | pubmed:author | pubmed-author:SanguinettiGG | lld:pubmed |
| pubmed-article:10831902 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10831902 | pubmed:volume | 26 | lld:pubmed |
| pubmed-article:10831902 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10831902 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10831902 | pubmed:pagination | 716-21 | lld:pubmed |
| pubmed-article:10831902 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:10831902 | pubmed:meshHeading | pubmed-meshheading:10831902... | lld:pubmed |
| pubmed-article:10831902 | pubmed:meshHeading | pubmed-meshheading:10831902... | lld:pubmed |
| pubmed-article:10831902 | pubmed:meshHeading | pubmed-meshheading:10831902... | lld:pubmed |
| pubmed-article:10831902 | pubmed:meshHeading | pubmed-meshheading:10831902... | lld:pubmed |
| pubmed-article:10831902 | pubmed:meshHeading | pubmed-meshheading:10831902... | lld:pubmed |
| pubmed-article:10831902 | pubmed:meshHeading | pubmed-meshheading:10831902... | lld:pubmed |
| pubmed-article:10831902 | pubmed:meshHeading | pubmed-meshheading:10831902... | lld:pubmed |
| pubmed-article:10831902 | pubmed:meshHeading | pubmed-meshheading:10831902... | lld:pubmed |
| pubmed-article:10831902 | pubmed:meshHeading | pubmed-meshheading:10831902... | lld:pubmed |
| pubmed-article:10831902 | pubmed:meshHeading | pubmed-meshheading:10831902... | lld:pubmed |
| pubmed-article:10831902 | pubmed:meshHeading | pubmed-meshheading:10831902... | lld:pubmed |
| pubmed-article:10831902 | pubmed:meshHeading | pubmed-meshheading:10831902... | lld:pubmed |
| pubmed-article:10831902 | pubmed:meshHeading | pubmed-meshheading:10831902... | lld:pubmed |
| pubmed-article:10831902 | pubmed:meshHeading | pubmed-meshheading:10831902... | lld:pubmed |
| pubmed-article:10831902 | pubmed:meshHeading | pubmed-meshheading:10831902... | lld:pubmed |
| pubmed-article:10831902 | pubmed:meshHeading | pubmed-meshheading:10831902... | lld:pubmed |
| pubmed-article:10831902 | pubmed:meshHeading | pubmed-meshheading:10831902... | lld:pubmed |
| pubmed-article:10831902 | pubmed:meshHeading | pubmed-meshheading:10831902... | lld:pubmed |
| pubmed-article:10831902 | pubmed:meshHeading | pubmed-meshheading:10831902... | lld:pubmed |
| pubmed-article:10831902 | pubmed:meshHeading | pubmed-meshheading:10831902... | lld:pubmed |
| pubmed-article:10831902 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:10831902 | pubmed:articleTitle | Double-masked prospective ocular safety study of a lens epithelial cell antibody to prevent posterior capsule opacification. | lld:pubmed |
| pubmed-article:10831902 | pubmed:affiliation | The Eye Department, St. Thomas' Hospital, London, United Kingdom. | lld:pubmed |
| pubmed-article:10831902 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10831902 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:10831902 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:10831902 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10831902 | lld:pubmed |
